Summary
Disposition characteristics of desipramine and its metabolite, 2-hydroxy-desipramine, were determined in four healthy male volunteers following an oral 50 mg dose of desipramine. Nonlinear least-squares regression of concentration-time data indicated that parent drug disposition could be described by a one-compartment open pharmacokinetic model for two subjects and by a two-compartment model for two subjects. The early appearance of 2-hydroxydesipramine and its high peak concentrations indicates that desipramine probably undergoes pre-systemic elimination partly through formation of 2-hydroxy-desipramine. The substantial production of 2-hydroxy-desipramine, as reflected by the area under its concentration-time curve which was 51% to 94% of that for desipramine, indicates that accumulation will occur following multiple dosing. As 2-hydroxy-desipramine may possess antidepressant activity, future studies designed to assess the therapeutic effect of desipramine should account for the presence of its pharmacologically active metabolite.
Similar content being viewed by others
References
Friedel RO, Veith RC, Bloom V, Bielski RJ (1979) Desipramine plasma levels and clinical response in depressed outpatients. Commun Psychopharmacol 3: 81–87
Amin MM, Cooper R, Khalid R, Lehmann HE (1978) A comparison of desipramine and amitriptyline plasma levels and therapeutic response. Psychopharmacol Bull 14: 45–46
Khalid R, Amin MM, Ban TA (1978) Desipramine plasma levels and therapeutic response. Psychopharmacol Bull 14: 43–44
Javaid JI, Perel JM, Davis JM (1979) Inhibition of biogenic amines uptake by imipramine, desipramine, 2-OH-imipramine, and 2-OH-desipramine in rat brain. Life Sci 24: 21–28
Potter WZ, Calil HM, Manian AA, Zavadil AP, Goodwin FK (1979) Hydroxylated metabolites of tricyclic antidepressants: Preclinical assessment of activity. Biol Psychiatry 14: 601–613
Potter WZ, Calil HM, Zavadil AP, Jusko WJ, Sutfin T, Rapaport JL, Goodwin FK (1980) Steady-state concentration of hydroxylated metabolites of tricyclic antidepressants in patients: Relationship to clinical effect. Psychopharmacol Bull 16: 32–34
Sutfin TA, Jusko WJ (1979) High performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites. J Pharm Sci 68: 703–705
Sedman AJ, Wagner JG (1976) CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 65: 1006–1010
Metzler CM, Elfring GL, McEwen AJ (1974) A user's manual for NONLIN and associated programs. Upjohn Co, Kalamazoo, Michigan
Yamaoka K, Nakagawa T, Uno T (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 6: 165–175
Gibaldi M (1975) Comparison of observed and predicted bioavailability of nortriptyline in humans following oral administration. J Pharm Sci 64: 1036–1037
Charalampous KD, Johnson PC (1967) Studies of C14-protriptyline in man: Plasma levels and excretion. J Clin Pharmacol 7: 93–96
Alexanderson B, Borgå O, Alván G (1973) The availability of orally administered nortriptyline. Eur J Clin Pharmacol 5: 181–185
Gram LF, Overø KF (1975) First-pass metabolism of nortriptyline in man. Clin Pharmacol Ther 18: 305–314
Gram LF, Christiansen J (1975) First-pass metabolism of imipramine in man. Clin Pharmacol Ther 17: 555–563
Sjöqvist F, Berglund F, Borgå O, Hammer W, Andersson S, Thorstrand C (1969) The pH-dependent excretion of monomethylated tricyclic antidepressants in dog and man. Clin Pharmacol Ther 10: 826–833
Alexanderson B (1972) Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses — A cross-over study. Eur J Clin Pharmacol 5: 1–10
Borgå D, Piafsky KM, Nilsen OG (1977) Plasma protein binding of basic drugs. I. Selective displacement from α1-acid glycoprotein by tris (2-butoxyethyl) phosphate. Clin Pharmacol Ther 22: 539–544
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeVane, C.L., Savett, M. & Jusko, W.J. Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers. Eur J Clin Pharmacol 19, 61–64 (1981). https://doi.org/10.1007/BF00558386
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558386